ProShares - Ultra Nasdaq Biotechnology (BIB) |
| 87.6364 3.336 (3.96%) 04-14 16:00 |
| Open: | 86.98 |
| High: | 87.91 |
| Low: | 86.98 |
| Volume: | 13,061 |
| Market Cap: | 74(M) |
| PE Ratio: | 24.82 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 102.68 |
| Resistance 1: | 87.91 |
| Pivot price: | 80.63 |
| Support 1: | 79.18 |
| Support 2: | 73.78 |
| 52w High: | 90.91 |
| 52w Low: | 39.47 |
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 14 Apr 2026
Booking 53.8% Gains in Biotech and Tightening Your Stops - Stock Investor
Tue, 14 Apr 2026
Getting Back into Technology Position - Stock Investor
Tue, 14 Apr 2026
Booking 66.08% and 65.25% Gains, with a Special Note on Bank of Ireland - Stock Investor
Mon, 13 Apr 2026
Buying a New Software Play and Locking in 2 Double-Digit Percentage Gains - Stock Investor
Mon, 13 Apr 2026
Bet Big on this Apple Supplier - Stock Investor
Mon, 13 Apr 2026
Biotech Breaks Out - Stock Investor
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
